Flubichin methanesulfonateAlternative Names: VUFB 12950
Latest Information Update: 14 Apr 2010
At a glance
- Originator VUFB
- Developer Zentiva
- Class Analgesics; Anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain